BrainGeneticsPeer-reviewed journal article
Biallelic loss-of-function OBSCN variants predispose individuals to severe, recurrent rhabdomyolysis
Macarena Cabrera‐SerranoiD, Laure CaccavelliiD, Marco SavareseiD, Anna ViholaiD, Manu E. JokelaiD, Mridul JohariiD, Thierry CapiodiD, Marine MadrangeiD, Enrico BugiardiniiD, Stefen BradyiD, Rosaline C. M. QuinlivaniD, Ashirwad MerveiD, R. ScalcoiD, David Hilton‐Jones, Henry HouldeniD, Halil İbrahim AydıniD, Serdar CeylaneriD, Sarah Drewes, Jerry E. VockleyiD, Rhonda L. TayloriD, Chiara L FollandiD, Aasta Kelly, Hayley Goullée, Emil YlikallioiD, Mari AuraneniD, , Gianina RavenscroftiD
Abstract
Rhabdomyolysis is the acute breakdown of skeletal myofibres in response to an initiating factor, most commonly toxins and over exertion. A variety of genetic disorders predispose to rhabdomyolysis through different pathogenic mechanisms, particularly in patients with recurrent episodes. However, the majority of cases remain without a genetic diagnosis. Here we present six patients who presented with severe and recurrent rhabdomyolysis, usually with onset in the teenage years; other features included a history of myalgia and muscle cramps. We identified ten bi-allelic loss-of-function variants in the gene encoding obscurin (OBSCN) co-segregating with disease. We show reduced expression of OBSCN and loss of obscurin protein in patient muscle. Obscurin is proposed to be involved in SR function and Ca2+ handling. Patient cultured myoblasts appear more susceptible to starvation as evidenced by a greater decreased in SR Ca2+ content compared to control myoblasts. This likely reflects a lower efficiency when pumping Ca2+ back into the SR and/or a decrease in Ca2+ SR storage ability when metabolism is diminished. OSBCN variants have previously been associated with cardiomyopathies. None of the patients presented with a cardiomyopathy and cardiac examinations were normal in all cases in which cardiac function was assessed. There was also no history of cardiomyopathy in first degree relatives, in particular in any of the carrier parents. This cohort is relatively young, thus follow-up studies and the identification of additional cases with bi-allelic null OBSCN variants will further delineate OBSCN-related disease and the clinical course of disease.
- Citations
- 31
- FWCI
- 3.28
- Field percentile
- top 7%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Novel variants in ryanodine receptor type 3 predispose to acute rhabdomyolysis due to impaired autophagy
Hortense de Calbiac, Laure Caccavelli, … Pascale de Lonlay·medRxiv·Mar 3, 2026
- Glycerolipid defects in skeletal muscle contribute to rhabdomyolysis in Tango2 deficiency
Jennifer G. Casey, Euri S Kim, … Vandana Gupta·bioRxiv·Nov 12, 2022
- Pathogenetic mechanisms of muscle-specific ribosomes in dilated cardiomyopathy
Michael Robert Murphy, Mythily Ganapathi, … Xuebing Wu·Nature Cardiovascular ResearchPeer-reviewed·Jan 6, 2026
- Ryanodine receptor 1 ( RYR1 ) patient-derived muscle cells recapitulate disease phenotypes in 2D and 3D culture models
Joshua S. Clayton, Jordan Crane, … Rhonda L. Taylor·bioRxiv·Jun 20, 2026
- TANGO2-related rhabdomyolysis symptoms are associated with abnormal autophagy functioning
H. de Calbiac, S. Montealegre, … P. de Lonlay·bioRxiv·Mar 29, 2023
- Integrated data from R405W desmin knock-in mice highlight alterations of mitochondrial function, protein quality control, and myofibrillar structure in the initial stages of myofibrillar myopathy
Sabrina Batonnet‐Pichon, Florence Delort, … Christoph Stephan Clemen·Journal of Cachexia Sarcopenia and MusclePeer-reviewed·Oct 30, 2025